Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.5T | 9.2T | 10.1T | 10.2T |
Cost of revenue | 6.1T | 5.4T | 6.0T | 6.4T |
Gross profit | 3.4T | 3.8T | 4.2T | 3.8T |
Operating expense | ||||
Research & development | 0 | 0 | 16.5K | -3.2B |
Selling general and admin | 238.3B | 183.9B | 368.6B | 235.1B |
Other operating expenses | 10.3B | 30.9B | -38.3B | 8.6B |
Operating income | 2.6T | 2.9T | 3.0T | 3.0T |
Non operating interest income | ||||
Income | 202.3B | 174.3B | 521.9B | 334.3B |
Expense | 1.5T | 1.3T | 1.5T | 1.2T |
Other income expense | — | — | — | — |
Pretax income | 1.5T | 1.5T | 2.7T | 2.6T |
Tax provision | 1.1T | 1.2T | 1.1T | 1.4T |
Net income | 360.2B | 337.8B | 1.6T | 1.2T |
Basic EPS | — | 0.0 | — | — |
Diluted EPS | — | 0.0 | — | — |
Basic average shares | — | 411.4T | — | — |
Diluted average shares | — | 411.4T | — | — |
EBITDA | 3.4T | 2.9T | 3.7T | 3.8T |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -47.8B | -53.7B | 33.6B |
Preferred stock dividends | 0 | 0 | 0 | 0 |